Anthocyanin-rich plum juice reduces ambulatory blood pressure but not acute cognitive function in younger and older adults: a pilot crossover dose-timing study by Igwe, Ezinne O et al.
University of Wollongong 
Research Online 
Illawarra Health and Medical Research Institute Faculty of Science, Medicine and Health 
2017 
Anthocyanin-rich plum juice reduces ambulatory blood pressure but not 
acute cognitive function in younger and older adults: a pilot crossover 
dose-timing study 
Ezinne O. Igwe 
University of Wollongong, eok167@uowmail.edu.au 
Karen E. Charlton 
University of Wollongong, karenc@uow.edu.au 
Steven J. Roodenrys 
University of Wollongong, steven@uow.edu.au 
Katherine Caldwell 
University of Wollongong, kc582@uowmail.edu.au 
Kent Fanning 
Queensland Government Department of Primary Industries and Fisheries 
See next page for additional authors 
Follow this and additional works at: https://ro.uow.edu.au/ihmri 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Igwe, Ezinne O.; Charlton, Karen E.; Roodenrys, Steven J.; Caldwell, Katherine; Fanning, Kent; and Netzel, 
Michael, "Anthocyanin-rich plum juice reduces ambulatory blood pressure but not acute cognitive function 
in younger and older adults: a pilot crossover dose-timing study" (2017). Illawarra Health and Medical 
Research Institute. 1137. 
https://ro.uow.edu.au/ihmri/1137 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
Anthocyanin-rich plum juice reduces ambulatory blood pressure but not acute 
cognitive function in younger and older adults: a pilot crossover dose-timing 
study 
Abstract 
Consumption of anthocyanins from fruit sources may exert protection against hypertension and improve 
cognition. However, the effect of dose timing in studies is rarely considered. We hypothesized that timed-
dose consumption of juice from an anthocyanin-rich Japanese plum variety (Queen Garnet plum, QGP) 
will have acute and dose-timing effects on cardiovascular responses, cognition, and urinary anthocyanin 
excretion profiles. Our study objective was to investigate the impact of plum juice on these health 
parameters. Twelve older (65+ years) and 12 younger (18-45 years) adults participated in an acute 
crossover study. Participants received, randomly, either 1 x 300 mL or 3 x 100 mL plum juice over 3 hours 
on 2 different occasions with a 2-week washout period. A battery of cognitive tasks was administered at 
0 and 6 hours on each study day. Blood pressure (BP) and urinary anthocyanin/metabolite excretion 
profiles were measured over 24 hours. Area under the curve for BP was calculated (0-6 hours). A 
significant reduction in BP and cardiovascular responses was observed in both age groups which was 
more obvious in the older age group on the single dose for systolic BP, diastolic BP, mean arterial 
pressure, and heart rate (P values =.035,.028,.017, and.006, respectively). No significant difference was 
observed between dose-timing regimens for either age group. There was no observed effect on cognition. 
Native QGP anthocyanins, as well as methylated/glucuronidated metabolites, were detected in urine with 
no significant differences between age groups or dose timing. High-anthocyanin plum juice significantly 
reduced BP, but dose timing did not appear to be a significant factor in the potential acute BP-lowering 
effect of QGP juice. 
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Abstract 44 
Consumption of anthocyanins from fruit sources may exert protection against hypertension 45 
and improve cognition. However, the effect of dose-timing in studies is rarely considered. We 46 
hypothesized that timed-dose consumption of juice from an anthocyanin-rich Japanese plum 47 
variety (Queen Garnet plum, QGP) will have acute and dose-timing effects on cardiovascular 48 
responses, cognition, and urinary anthocyanin excretion profiles. Our study objective was to 49 
investigate the impact of plum juice on these health parameters. Twelve (12) older (65y+) 50 
and 12 younger (18-45y) adults participated in an acute crossover study. Participants 51 
received, randomly, either a 1x300ml or 3x100ml plum juice over 3h on two different 52 
occasions with a 2-week washout period. A battery of cognitive tasks was administered at 0h 53 
and 6h on each study day. BP and urinary anthocyanin/metabolite excretion profiles were 54 
measured over 24h. Area under the Curve for BP was calculated (0-6h). A significant 55 
reduction in BP and cardiovascular responses was observed in both age groups which was 56 
more obvious in the older age group on the single dose for SBP, DBP, Mean Arterial Pressure 57 
and Heart Rate (p-values=0.035, 0.028, 0.017 and 0.006 respectively). No significant 58 
difference was observed between dose-timing regimens for either age group. There was no 59 
observed effect on cognition. Native QGP anthocyanins, as well as 60 
methylated/glucuronidated metabolites were detected in urine with no significant differences 61 
between age groups or dose-timing. High anthocyanin plum juice significantly reduced blood 62 
pressure but dose-timing did not appear to be a significant factor in the potential acute BP-63 
lowering effect of QGP juice.  64 
Keywords: Anthocyanins, Blood Pressure, Queen Garnet plum juice, Cognition, Acute, 65 
Cross-over, human  66 
5 
 
1. Introduction 67 
 68 
Elevated and high blood pressure is a major public health concern and a significant risk factor 69 
for cardiovascular diseases. According to the World Health Organization (WHO), the 70 
prevalence of high blood pressure in adults aged 18 and over was around 22% in 2014. This 71 
accounted for about 9.4 million deaths or  7% of  all deaths [1]. In Australia, between 2011 72 
and 2012, almost one-third (31.6%) of all adults were  diagnosed with hypertension, which 73 
was more prevalent at older ages, with almost 9 in 10 (87.7%) people aged 85 years and older 74 
being  hypertensive [2]. In  global strategies to address non-communicable diseases including 75 
hypertension, the significant role of modifiable dietary risk factors, including an increased 76 
intake of fruits and vegetables is acknowledged [3]. Small (2-5mmHg) but steady decreases 77 
in mean blood pressure have been shown to significantly decrease the incidence of 78 
cardiovascular events [4]. Given the magnitude of hypertension, and its contribution towards 79 
the burden of cardiovascular disease, cost-effective strategies including dietary intervention 80 
are needed for its prevention and management. Plant-based foods are integral to a healthy 81 
human diet and a plant-rich diet is associated with the prevention of a vast array of diseases 82 
[5]. Bioactive compounds of interest include polyphenols, which are found mainly in plant 83 
based foods and have antioxidant properties. More than 8000 different polyphenols have been 84 
identified in nature within four different categories (flavonoids, phenolic acids, lignans and 85 
stilbenes). Over the past decade, there has been increased research into flavonoids, notably, 86 
anthocyanins for their beneficial health effects [6]. 87 
 88 
Anthocyanins, the largest subclass of flavonoids, comprise a group of water-soluble 89 
phytochemicals known to be responsible for the deep rich red to blue-purple colors in fruits 90 
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and vegetables [7]. There is some evidence  from epidemiological studies that suggests a 91 
higher consumption of anthocyanin-rich foods is associated with a reduced  risk for  92 
cardiovascular disease [8, 9]. However,  intervention studies do not always support these 93 
findings  [10]. In the case of blood pressure, plausible mechanisms from experimental studies 94 
include their effects on vascular blood flow and flow-mediated dilation (FMD) [11, 12].  95 
 96 
It has been hypothesized that anthocyanins may exert protective effects on cognition, 97 
including memory and executive processing, either through a direct effect on brain function 98 
or indirectly by reducing blood pressure [13-15]. One of the main pathways linking blood 99 
pressure to cognitive degeneration is the decline in vascular reserve capacity which is 100 
associated with impaired neurovascular coupling [16]. Despite evidence from 101 
epidemiological and intervention studies indicating that anthocyanin intake is linked with 102 
improved cognition [15, 17] and a slower cognitive decline [18], the mechanisms by which 103 
anthocyanins may exert acute effects on brain function remains unclear and evidence is 104 
inconsistent. A crossover study by Caldwell et. al. (2016) [19] found that high anthocyanin 105 
cherry juice consumption did not result in any significant acute effects on a battery of 106 
cognitive tests in either younger or older adults. Contrary to this, Watson et.al, (2015) [20] 107 
observed a cognitive benefit of acute blackcurrant supplementation in healthy younger adults 108 
possibly explained by an association between monoamine oxidase (MAO) inhibition and 109 
improved attention. There is a possibility that the inhibition of MAO have positive effects on 110 
monoaminergic neurotransmission during cognitive performance [21]. This is as a result of 111 
monoamine levels, particularly for dopamine, being shown to increase during cognitive tasks 112 
(which assess working memory and attention) with a positive correlation with task 113 
performance [21]. An acute effect on cognition by fruit anthocyanin supplementation has also 114 
been observed in children [17, 22].  115 
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 116 
Inadequate understanding of the uptake, metabolism distribution and excretion of 117 
anthocyanins has limited the design of clinical trials that investigate their effect on health 118 
outcomes. The body of evidence on the protective effects of flavonoid-rich foods against 119 
CVD is based mainly on epidemiological studies, thus evidence remains inconclusive and 120 
acute effects have not been well defined.  Systematic reviews of available experimental 121 
studies [23, 24] have highlighted an absence of knowledge regarding a ‘threshold dose’ or 122 
appropriate ‘dose-timing’ required to induce physiological protective effects. This is because 123 
the impact of anthocyanin dose has not been studied extensively in humans and different 124 
experiments have used varied preparations e.g. juice, puree and whole fruit. Consequently, 125 
studies administer unfeasibly large doses of anthocyanin-rich foods in order to elucidate a 126 
physiological response, and the selection of dose-timings is often unsubstantiated [25-27]. 127 
While splitting a large daily dose of anthocyanin-rich food into three or more servings per 128 
day may reflect a more feasibly tolerated serve, there is often no justification as to the reason 129 
each dose was selected, and no consideration given to the physiological effects. Even though 130 
results have mostly been in agreement, evidence shows that beyond a point, the 131 
bioavailability of anthocyanins decreases with increasing dose [28]. For cyanidin-based 132 
anthocyanins the maximum absorption has been reported to be about 350µmol or less. This is 133 
also believed to differ according to the  structure of different anthocyanins, the  attached 134 
sugar moiety and because of wide inter-individual variation in metabolism which limits 135 
translation of research findings into dietary messages [29]. Taking these factors into 136 
consideration, there is a need to better understand the acute effects of   anthocyanins provided 137 
from different foods and beverages, in order to identify any consistent potential health 138 
benefits.   139 
 140 
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The increased interest in anthocyanin-based research has translated into agricultural 141 
responses, as the demand for fruits with superior health benefit grows. An  example is the 142 
Queen Garnet plum (QGP), that is a variety of the popular Japanese plum Prunus salicina 143 
Lindl that was bred by the Queensland Government to be very high in anthocyanins,  144 
providing up to 277 mg/100 g fruit [30] under “optimal” environmental and harvest 145 
conditions. This   is more than twice the anthocyanin content of regular plums that ranges 146 
from 5 to 173mg/100g across harvest years [30]. Previous work from our group has 147 
determined the acute effect of anthocyanins provided from a different fruit source (cherries) 148 
[15, 31]. Learnings from those studies underpins the improved methodologies employed in 149 
the current study, particularly with regard to more robust assessment of 24 hour BP and 150 
measurement of urinary anthocyanin metabolites. Furthermore, the QGP juice has a 151 
completely different anthocyanin and non-anthocyanin polyphenol profile compared to the 152 
Australian cherry juice vehicle used previously [15, 31] which may influence its 153 
synergistic/antagonist effects on biological activities. Our previous acute trial found that 154 
plasma levels of anthocyanin-related metabolites were significantly lower for older adults, 155 
but not for younger adults, who consumed cherry juice over 3 smaller servings (3 x 100ml), 156 
compared to consumption of 300ml at a single time point. This finding warrants further 157 
research consideration. 158 
 159 
As a follow-up, this study hypothesized that the consumption of high anthocyanin QGPJ will;  160 
1. have an acute beneficial effect on various domains of cognitive functioning and blood 161 
pressure,  162 
2. be found to be  bioavailable through the presence of anthocyanin metabolites excreted 163 
in the urine  over a 24 h period and,  164 
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3. Show differences in the absorption rate and metabolism of anthocyanins between 165 
young and older adults. 166 
From the above hypotheses, the primary aim of this study was to determine the dose-timing 167 
response on acute ambulatory blood pressure and cognitive function following consumption 168 
of 300ml QGP juice, provided as either a single dose or three 100ml quantities over 3h, in 169 
young and older adults. The secondary outcome was to determine the bioavailability of QGP 170 
anthocyanins, as assessed by urinary excretion over a 24h period, and to assess any 171 
significant differences in the anthocyanin/metabolite profiles between young and older adults. 172 
 173 
2. Methods and Materials 174 
 175 
This study was conducted according to the guidelines laid down in the Declaration of 176 
Helsinki and all procedures involving human subjects were approved by the University of 177 
Wollongong Human Research Ethics Committee NSW, Australia (HE16/278). Written 178 
informed consent was obtained from all participants.  179 
 180 
2.1. Study design 181 
 182 
The study was a pilot cross-over bioequivalence/non-inferiority study to assess the acute 183 
impact differing dose-timings of high-anthocyanin plum juice consumption on acute 184 
cognition and blood pressure over 24h. This study was considered a bioequivalence/non-185 
inferiority design due to the dosage for the two crossover arms being the same (a single 186 
300ml and 3x100ml over 3 h) with the aim to determine whether three 100ml of plum juice 187 
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taken over three hours would have a different pattern of effect on blood pressure in 188 
comparison to a single 300ml dose. Results from this pilot study will inform the methodology 189 
as well as sample size calculation for a future crossover randomized clinical trial. This is in 190 
line with the assumptions of bioequivalence studies whereby the future trial will be designed 191 
as a crossover study [32-34]. 192 
 193 
2.2. Participants 194 
 195 
All participants were recruited from the University of Wollongong (UOW) and the 196 
surrounding Wollongong areas through poster advertising. Potential participants had the 197 
opportunity to discuss the study over the phone prior to clinic visits and were screened to 198 
determine eligibility. 199 
 200 
Twenty-four participants were recruited, including 12 younger (18-45y) and 12 older (65+y) 201 
adults. The sample size was determined according to recommendations for planning a pilot 202 
study that investigates bioavailability and bioequivalence of components within food [32-34].  203 
 204 
Recruited eligible participants were randomized to a dose-timing allocation and cognitive 205 
assessment order by a computer-generated block randomization by an independent 206 
statistician. Participants attended two 6-h clinic visits at the Illawarra Health and Medical 207 
Research Institute (IHMRI) at the University of Wollongong, NSW, Australia between June 208 
and September 2015 with at least a two-week washout period between clinic visits.  209 
 210 
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2.3. Exclusion criteria 211 
 212 
Exclusion criteria included self-reported uncontrolled hypertension, any unstable physical or 213 
mental health condition, inability to provide informed consent, consumption of specific daily 214 
health supplements, and inability to communicate in the English language.  215 
 216 
2.4. Data collection 217 
 218 
On the first study day, a questionnaire was administered to determine participants’ socio-219 
demographic characteristics. The International Physical Activity Questionnaire (IPAQ) 220 
validated by Hagströmer, Oja [35] was used to  determine habitual level of physical activity 221 
and blood pressure measurements were taken using an ambulatory blood pressure monitor 222 
(ABPM) (SpaceLabs Inc., Issaquah, WA, Australia; Model 90207).  223 
 224 
2.4.1. Dietary instruction and intervention meals  225 
 226 
The QGP juice was used as the vehicle to provide a specific and consistent anthocyanin dose 227 
to study participants. The plum juice was produced from a single seasonal batch and 228 
processed to juice by research partners at the Department of Agriculture and Fisheries (DAF), 229 
Queensland Government, and was batch frozen at -20oC until usage [36]. 230 
 231 
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Prior to each study day, participants were advised to avoid consumption of purple/red fruits 232 
and vegetables including wine, juices, jams and smoothies in the 24h periods immediately 233 
before and after interview day. Verbal compliance to this was received prior to the study. On 234 
each study day participants arrived between 08:00 and 09:30 hours at the clinic facility 235 
following a 12h fast. A spot urine sample was collected and a battery of cognitive tests 236 
administered by two interviewers who had been trained by a senior psychologist (SR). 237 
Thereafter, a standardized breakfast (Weet-Bix, milk and sugar) that was low in flavonoids 238 
was provided. QGP juice was provided with breakfast in random order, as either (i) a single 239 
dose of 300ml (369 mg total anthocyanins) or (ii) 3 x 100ml servings (123mg total 240 
anthocyanins/serving) of the same plum juice at 0, 1 and 3h. A standardized snack (ham and 241 
cheese sandwich) was provided at 4h and two (250ml) bottles of water provided for the 6h 242 
duration spent in the study facility to be consumed ad libitum. 243 
 244 
2.4.2. Ambulatory 24h blood pressure and anthropometric measurements 245 
 246 
Blood Pressure was measured using Ambulatory Blood Pressure Monitors (ABPM) for 247 
improved monitoring over 24 h in comparison to standard digital blood pressure monitors 248 
used in similar studies over a 6-hour period [15, 31]. 249 
 250 
Upon arrival at the testing facility participants were fitted with an ABPM (SpaceLabs Inc., 251 
Issaquah, WA, Australia; Model 90207). The ABPM took blood pressure measurements over 252 
the next 24 h; every 15 minutes while at the testing facility (first 6 h) and thereafter once per 253 
hour whilst at home. The ABPM uses an oscillometric method for the detection of systolic 254 
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and diastolic blood pressure and has been shown to be more accurate than casual or in-office 255 
BP measurements [37]. Participants were encouraged to go about their usual daily activities, 256 
but were advised to stand still and relax their arm whenever the monitor recorded 257 
measurements i.e. cuff inflation and deflation. After 24 hours, the monitor was removed and 258 
collected from participants’ homes and data downloaded from the monitor for analysis. 259 
 260 
Height (m) and weight (kg) were measured using a stadiometer (Seca, Hamburg, Germany) 261 
and an electronic scale (Omron HN286 Digital Personal Body Weight Scale, (Omron, 262 
Australia)) respectively, to two decimal places and BMI (weight/ (height2)) was calculated. 263 
 264 
2.4.3. Cognitive tasks  265 
 266 
Five short cognitive interviewer-administered tests [38, 39] were administered by trained 267 
investigators at baseline and 6h on both testing occasions to determine any acute changes in 268 
cognition.  269 
 270 
The total duration of the battery of tasks was approximately 30min. To control for cross-over 271 
effects, there were 4 versions of the cognitive battery so that each participant had a different 272 
version at baseline and 6h and also after cross-over period.  273 
 274 
The Trail Making Test [40] required participants to alternate selective responses between two 275 
types of stimuli in the one task. The difference in the number of seconds required to complete 276 
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the task was compared to a non-switching version. This task assesses higher executive 277 
function.  278 
 279 
In the Rey Auditory Verbal Learning test (RAVLT) [41], participants learn and recall a list of 280 
words over 5 trials and each correct word that is identified is associated with a score. This 281 
task assesses verbal learning and memory. 282 
 283 
The Pattern and Letter Comparison task [42] requires participants to compare strings of 284 
patterns or letters to determine if it is the same or different. They are required to complete as 285 
many examples as possible in 30sec and scores are tallied. This task assesses speed of 286 
processing. 287 
 288 
The Reaction Time task [43] involves display of a left or right arrow-shaped stimulus on the 289 
computer screen and participants are required to press the corresponding mouse button (left 290 
or right). Outcome variables are proportion of correct responses and latency (response speed). 291 
This task assesses general alertness and speed of processing.  292 
 293 
The Stroop task [44] provides participants with a sheet on which the words “purple,” “green,” 294 
“yellow,” “red,” and “blue” are printed (50 in total). Each word is shown in either congruent 295 
or incongruent ink colors (e.g. the word “blue” printed in red). Participants are instructed to 296 
read out the actual color and not the printed word as quickly as possible. The amount of time 297 
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taken (seconds) to complete each set of words was recorded. This task assesses executive 298 
function. 299 
 300 
2.4.4. Urine sample collection and preparation 301 
 302 
Urine samples were collected at baseline prior QGP juice consumption, and thereafter 303 
collected in sterilized urine containers over the following time periods:  0-2h; 2-6h; 6-12h and 304 
12-24h after QGP juice consumption. The volume of collected urine samples were measured 305 
per container, recorded and an aliquot of 30ml of urine sample plus 9ml of formic acid 306 
(100%) stored in 50ml tubes, with additional 10ml urine for storage. The urine samples were 307 
stored at -800C for batch analysis. Intact (non-metabolized) QGP anthocyanins (cyanidin-3-308 
glucoside and cyanidin-3-rutinoside) as well as their main/common conjugated and 309 
methylated metabolites such as peonidin-glycosides and –glucuronides were determined by 310 
HPLC-PDA-MS as described by Netzel et. al. (2012) [36].  311 
 312 
2.5. Statistical Analyses 313 
 314 
Data was analyzed using IBM SPSS Statistics for Windows, Version 21.0. (IBM Corp., 315 
Armonk, NY, USA). Descriptive statistics of participant characteristics was performed across 316 
age groups. Normal distribution of the continuous variables was assessed using the Shapiro 317 
Wilk test, histogram, Q-Q plot and skewness and kurtosis.  318 
 319 
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Linear mixed modelling was used to estimate the effect of different timed doses of QGP juice 320 
on BP between the two age groups, while adjusting for correlation due to repeated 321 
observations on each participant over 24h. Age-group and dose (with interaction term) were 322 
entered in the model as fixed effects while controlling for age and gender. Maximum 323 
likelihood method of estimation was used with a diagonal covariance structure. As blood 324 
pressure measurements were collected over 24h, there were a few missing data (less than 1%) 325 
and as a result linear mixed modelling was chosen for analysis as it handles missing data 326 
better than the widely used ANCOVA.  327 
 328 
Area Under the Curve (AUC) was calculated as a summation measure for the first 6h of BP 329 
measurements and the baseline observation carried forward (BOCF) approach was used for 330 
missing data (less than 1%). To determine if the plum juice had a significant effect on BP, a 331 
z-test was used to analyze the AUC for the BP. A series of t-tests was used to determine 332 
whether there was any significant difference between baseline BP and different time points 333 
up to 6h. The period between 0 and 6h represents the time that the participants spent at the 334 
study facility under standard resting conditions.  335 
 336 
One-way analysis of variance (ANOVA) was used to determine differences in performance 337 
within each group at baseline and 6h post-intervention and two-way ANOVA was used to 338 
determine the difference in cognitive performance at baseline and 6h between the two age 339 
groups and dosing regimens as well as anthocyanin excretion between the two age groups. 340 
 341 
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3. Results 342 
 343 
3.1. Subject characteristics 344 
 345 
Twenty-four participants (12 young and 12 old adults) were recruited to participate in the 346 
study and sociodemographic characteristics are shown in Table 1. Participants were of 347 
Caucasian descent (n=21), African descent (n=2) and Asian (n=1). All participants attended 348 
both visits and there were no withdrawals, nor adverse events reported throughout the study 349 
protocol. The average washout period for participants was 20 days, a deviation from the 350 
original 2-week washout period due to schedule clashes and illness. The washout period 351 
chosen for our study was 2 weeks. This was informed by the FDA recommendation which 352 
states that for bioequivalence studies, “The washout time should be approximately 10x the 353 
plasma apparent terminal elimination half-life, to provide for 99.9% of the administered dose 354 
to be eliminated from the body.” [45]. For the anthocyanin, cyanidin-3-glucoside, which is 355 
the main anthocyanin in QGP juice [36, 46], the half-life has been shown to range between 12 356 
and 51h [47]. 357 
 358 
3.2. 24h ambulatory blood pressure  359 
 360 
Hourly cardiovascular responses recorded during each of the 24h test periods are shown, 361 
according to plum juice delivery mode in Figures 1-4. Comparison is made between the 362 
dosing regimen (single and triple doses) and age groups with an interaction factor (dosing 363 
regimen x age-group). Figure 1a shows a more obvious drop in systolic blood pressure of the 364 
older adults with the single dose compared to the triple dose (Figure 3a). This observation 365 
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was not evident with the younger adults, as shown in Figures 1a and 3a. There was no 366 
significant dose-timing effect observed for change in blood pressure following plum juice 367 
consumption in the 24h period using the linear mixed model for longitudinal data (Table 2).  368 
 369 
Area under the curve (AUC) was calculated for the cardiovascular parameters (systolic, 370 
diastolic, MAP and HR) for the first 6h (Figures 5-6 and Table 3). For both age groups, using 371 
a t-test, BP was significantly lower than baseline (p < 0.05) at different time points up to 6 h 372 
following consumption of the plum juice. The greatest significant BP reduction was observed 373 
at 2h for both age groups and was more obvious for systolic BP in the older group with a 374 
mean difference of 12.83mm Hg (SD; 16.51, p=0.001) from baseline. For the single dose, z-375 
test analysis of the AUC calculations for the younger adult group showed a significant effect 376 
of the juice on diastolic BP, MAP and HR (p-values = 0.008, 0.012 and 0.025 respectively). 377 
Similarly, a significant effect was seen for the older group: systolic BP, diastolic BP, MAP 378 
and HR (p-values = 0.035, 0.028, 0.017 and 0.006 respectively). For the younger age-group 379 
on the triple dose, significant effects were observed for diastolic BP and MAP (p-values = 380 
0.008 and 0.013 respectively) with a borderline significance on the HR (p-value = 0.06). In 381 
the older group, significant effects of the triple dose were observed for diastolic BP (p-value 382 
= 0.00007) and a borderline effect for systolic BP (p-value = 0.063). Plum juice consumption 383 
had a significant effect on systolic BP, which was predicted by dose or age group but no 384 
interaction term effect (dose x age group) and for MAP, predicted by only age-group. No 385 
significant effect was observed on other cardiovascular parameters (table 2). 386 
 387 
3.3. Cognitive tasks 388 
 389 
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Using two-way ANOVA, a significant difference was observed between the two age groups 390 
(p<0.001), both at baseline and 6h, for performance on cognitive tests. After consumption of 391 
the juice, there was no significant difference from baseline values within the groups or by 392 
dose-timing. 393 
 394 
3.4. Urinary excretion of anthocyanins and anthocyanin metabolites 395 
 396 
The anthocyanin content of the batch of QGP utilized for our study was 123mg/100g. The 397 
consumption of QGP juice as a single oral dose of 300ml or in threex100ml servings over 3h 398 
resulted in the appearance of both intact/non-metabolized QGP anthocyanins (cyanidin-3-399 
glucoside and cyanidin-3-rutinoside) and at least five identified anthocyanin metabolites in 400 
the volunteers’ urine samples (Table 4). The excretion rates and urinary 401 
anthocyanin/metabolite profiles were similar (p>0.05) between age groups and dosing 402 
regimen. 403 
 404 
4. Discussion 405 
 406 
Following consumption of a single dose of 300ml dose of plum juice, an acute reduction in 407 
SBP (p=0.035), DBP (p=0.028), MAP (p=0.017) and HR (p=0.006) was observed in the 408 
older age group. A similar trend was also observed for the triple dose with the absence of an 409 
effect on SBP. This acute effect was more pronounced in the older age group and at 2h with a 410 
mean difference of 12.83mm Hg from baseline. Significant effects on DBP (p<0.001) and 411 
MAP (p=0.013) were also observed in the younger age group on the single dose and DBP 412 
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(p<0.001) with a borderline effect on SBP (p=0.06) on the triple dose. The acute significant 413 
reduction in blood pressure at 2h is associated with evidence on the absorption and 414 
bioavailability of anthocyanins that occurs within 2h post consumption [48]. Anthocyanin 415 
concentrations in the body have been observed to reach peak levels between 1-2h and begin 416 
to clear from 6h falling back to baseline levels as they get excreted from the body up to 48h 417 
[49]. The synergistic effect of other nutrients in the Queen Garnet plum cannot be 418 
overlooked. There is a possibility that the observed blood pressure lowering effect may have 419 
been as a result of this synergistic effect, as well as the presence of potassium in the Queen 420 
Garnet plum fruit [30] which is an electrolyte know to lower blood pressure in humans [50]. 421 
Despite lack of a significant effect of dose by the different age groups on blood pressure, the 422 
greater reduction in blood pressure in response to plum juice consumption in older adults may 423 
be explained by their higher baseline blood pressure levels [4]. However, further adequately 424 
powered studies are needed to confirm these findings. In the 6 h following the plum juice 425 
consumption no significant effect was observed on the SBP of the younger age group. Similar 426 
observation has also been made in previous studies. A study by Novotny, Nigg [51] observed 427 
that the PacDASH (Pacific Kids Dietary approach to stop hypertension) trial did not affect 428 
overall diet quality which was measured by SBP change among other parameters but had a 429 
significant effect on DBP by the end of the intervention, by 12.2 mmHg. There is a 430 
possibility that the absence of a significant effect on SBP could be associated with age 431 
because there is a possibility that interventions may have a more significant effect among 432 
older populations and/or those more prone to age-related vascular stiffening with an increased 433 
risk of developing CVD.  434 
 435 
There was an observed dose-timing and group effect on SBP but not on other blood pressure 436 
parameters, however, this was no longer significant after inclusion of an interaction term 437 
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(age-group x dose-timing).  Previously, a similar study observed an acute reduction in blood 438 
pressure (SBP, DBP and HR) after consumption of anthocyanin-rich cherry juice, which was 439 
found to be dose-timing dependent [31]. The difference between the two studies may be 440 
explained by a much higher concentration of anthocyanins in the QGP juice (123mg/100ml 441 
vs 69mg/100ml, respectively), resulting in a physiological threshold to be reached in each of 442 
the three 100ml doses. 443 
 444 
A possible explanation/mechanism of the observed blood pressure lowering effect of QGP 445 
juice could lie in the molecular structure of its main in vivo anthocyanin metabolites. The 446 
described methylation of cyanidin glycosides by catechol-O-methyltransferase (COMT) to 447 
peonidin based metabolites as the main urinary anthocyanin metabolites after QGP juice 448 
ingestion results in a structural modification of the B-ring in the flavonoid skeleton which is 449 
structurally analogous to apocynin, an established vasoactive drug [8, 52, 53]. Mono-O-450 
methylated anthocyanins/flavonoids can act as inhibitors of NADPH oxidase and as a result 451 
can improve vasodilatory processes [8]. Another possible explanation for the blood pressure 452 
lowering effect of anthocyanins and/or other polyphenols present in the plum juice is their 453 
potential to inhibit the oxidation of Low-Density Lipoproteins (LDLs), a major risk factor for 454 
atherosclerosis, through free-radical scavenging and removal of metal ions from catalytic 455 
sites via chelation [54]. The mechanism by which OxLDL promotes atherogenesis is believed 456 
to be through cytotoxicity, inhibitory effects on macrophage motility, and uptake by the 457 
macrophage scavenger receptor resulting in stimulation of cholesterol accumulation and 458 
hence foam cell formation, which is critical in early atherosclerosis lesions. To test this 459 
theory, Liu, Lee [55] in their study observed that when cells were incubated with OxLDL 460 
(100 µg/ml) for 24 h, they was an increase in cell death while the additions of mulberry water 461 
extracts and mulberry anthocyanin-rich extracts beyond the concentrations of 0.1 and 0.05 462 
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mg/ml, respectively, significantly increased the survival of these cell macrophages. They also 463 
observed that 1 mg/ml of mulberry water extracts and 0.1 mg/ml of mulberry anthocyanin-464 
rich extract suppressed the lipid accumulation by approximately 55% and 58%, respectively.  465 
 466 
Even though anthocyanins have been hypothesized to promote healthy brain functioning, 467 
results from our pilot study show that a 300ml serving of plum juice, regardless of dose-468 
timing or age of participants, has no significant acute effect on various domains of cognitive 469 
function. Although previous studies have found no significant acute effect of anthocyanins 470 
from fruit source on cognitive processes, the QGP juice used in the present study had a 471 
significant higher content of anthocyanins and therefore there was a possibility that it might 472 
induce cognitive effects. In addition, two different cognitive tests that have been shown to be 473 
sensitive and target different domains were utilized; Stroop and the Reaction time task [39, 474 
56]. Extensive research has been carried out on the long term effect of flavonoid 475 
supplementation on cognition [39] with less attention on their acute effects. Recently, there 476 
has been an increase in the body of evidence on the acute effects of flavonoids on cognitive 477 
processes such as attention, working memory and psychomotor speed in a general population 478 
[57]. The precise mechanism by which anthocyanins affect cognition is still not clear but 479 
seems to be dependent on the exposure period. Acute effects on cognition are believed to be 480 
as a result of increased cerebrovascular blood flow and possibly monoamine oxidase (MAO) 481 
inhibition which has been shown to improve cognitive performance [14, 20]. Following 482 
consumption of high anthocyanin fruit/juice, evidence shows that peaks in cerebral blood 483 
flow, vasodilation, and anthocyanin metabolite availability is detectable within 2h post 484 
consumption [17]. Following blueberry supplementation plasma anthocyanins and their 485 
metabolites were observed to reach peak levels at 1–2h and 6h [11]. An investigation on the 486 
bioavailability of anthocyanins observed an association between colon microbiota 487 
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metabolism of anthocyanins and a significant increase in the content of generated 488 
polyphenols in the brain. There is a possibility that the peak levels observed at 6h is as a 489 
result of re-uptake of polyphenols in the colon [58, 59]. For this reason, repeat cognitive tasks 490 
were administered 6 h post consumption of the plum juice for our study. The absence of a 491 
significant effect could be attributed to the timing of cognitive task administration, missing 492 
the initial peak action time. Move cogntion para up here 493 
 494 
The urinary recovery of intact anthocyanins and anthocyanin metabolites that had an intact 495 
flavonoid skeleton (glucuronides, sulfates and methylated forms) was between 693 and 871 496 
ug/24 h, corresponding to 0.19 – 0.24% of the ingested anthocyanin dose. These ranges   are 497 
consistent with those reported in human studies for urinary excretion rates of anthocyanins 498 
and conjugated/methylated metabolites after consumption of anthocyanin-rich food (0.01 – 499 
5.10%) [7, 36, 60]. The bioavailability of anthocyanins has been reported to be low however 500 
a recent review indicates that it may be higher than previously reported [61]. Evidence from 501 
this review showed that the majority of ingested anthocyanins reach the large intestine. Here 502 
they are catabolized by the microbiota, producing an array of phenolic components that are 503 
absorbed, and some metabolized to phase II conjugates [61]. Furthermore, our finding that 504 
methylated and glucuronidated derivatives of cyaniding-based anthocyanins were the main 505 
urinary metabolites is also in agreement with others [62-64]. The in vivo glucuronidation, 506 
sulfatation and methylation of anthocyanins by UDP-glucuronosyltransferases, 507 
sulfotransferase and COMT in the intestinal epithelial cells, liver and kidney is a common 508 
metabolic pathway of dietary anthocyanins and other polyphenolic compounds [65]. 509 
 510 
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The presence of pelargonidin monoglucuronide, when QGP juice does not contain any 511 
(detectable) pelargonidin based anthocyanins, can be explained by the in vivo xenobiotic and 512 
gut bacterial metabolism of anthocyanins/flavonoids. This includes addition and removal of 513 
methyl and hydroxyl groups (pelargonidin is lacking of one hydroxyl group compared to 514 
cyanidin) [66]. Furthermore, Kalt and colleagues reported similar results. After the ingestion 515 
of blueberry juice, which did not contain any detectable pelargonidin glycosides, significant 516 
amounts of pelargonidin based metabolites could be detected in the urine of 17 study subjects 517 
[66]. The described interconversion of anthocyanins due to xenobiotic and bacterial 518 
metabolism was suggested by these authors. In the current study there were no significant 519 
differences in the urinary anthocyanin/metabolite excretion profiles either between the age 520 
groups or according to the different dosing regimens (1x300 ml dose or 3x100 ml servings).  521 
 522 
Previous research has reported conflicting results regarding the influence of flavonoids on 523 
cognition in younger and older people. In one study, anthocyanin-rich blueberry 524 
supplementation in younger and older adults resulted in improvements in different acute 525 
cognitive domains, whereby a significant improvement in updating ability was reported for 526 
younger adults and improvements in immediate word recognition in older adults were 527 
identified [67]. In relation to cocoa flavonoids, consumption of dark chocolate for one week 528 
significantly improved endothelial function and reduced BP in younger hypertensive patients, 529 
but not in older populations [68]. Overall there is little information that compares responses 530 
between younger and older adult populations thus more work comparing these groups is 531 
required to elucidate any age-related differences in biological response.  532 
 533 
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The main objective with the dose-timing design was to estimate the response according to the 534 
dose given, in order to analyze the effect and identify any adverse reactions. Throughout the 535 
course of the study, the juice was well tolerated and there were no reports of any adverse 536 
effects, however the tolerability to the study protocol was not objectively measured. As there 537 
is large observed inter-individual variation in the absorption, metabolism and excretion of 538 
polyphenols [69], the use of a cross-over study design is appropriate since participants act as 539 
their own controls [70]. 540 
 541 
4.1.  Limitations of study 542 
 543 
A notable limitation of our study is the absence of a placebo arm. While a placebo arm is 544 
essential in dietary intervention studies in order to identify the magnitude of effect related to 545 
the dietary factor of interest. In the case of anthocyanins, Johnson et. al. (2015)[71] included 546 
a placebo control group in their  blueberry powder (469mg of anthocyanins/day) study and 547 
identified a drop of 7mmHg and 5mmHg after 8 weeks of intervention in both SBP and DBP 548 
(P<0.05 and P<0.01, respectively) but not in the control group. The main purpose of our 549 
acute study in which each participant   acted as their own control was to identify whether 550 
different dosing regimens of a high anthocyanin fruit juice resulted in differences for ether 551 
cognitive performance and/or BP. Information related to the dose-timing administration of an 552 
intervention is an important consideration in clinical trial designs in free-living participants. 553 
Furthermore, neither intact anthocyanins nor their common metabolites such as glucuronides, 554 
sulfates or methylated forms are usually detectable in urine of placebo/control groups as it 555 
was demonstrated in a pilot study with QGP juice and water as a control [36]. Food or 556 
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beverages used for placebo/control treatments are usually anthocyanin-free or contain only 557 
negligible amounts of these pigments. 558 
Previous chronic flavonoid trials have instructed participants to consume an amount of food 559 
or beverage over the period of a day, but without specific guidelines on whether this needs to 560 
be consumed in totality at a single setting or whether smaller portions can be spread across 561 
the day. Nonspecific information on timing of the test food or beverage probably relates to a 562 
poor understanding of how dose-timing may affect biological responses.  563 
 564 
Another notable limitation is the absence of a double-blinded strategy. This, in addition to 565 
cognitive testing time, could have resulted in the absence of a significant effect on cognitive 566 
performance after consumption of the plum juice. A consideration for future studies could be 567 
to test cognitive effects 2 h and 4-6 h post consumption in order to reflect metabolic 568 
processes and thus consolidate available evidence. Another important consideration for future 569 
clinical trials may be to screen for individuals with arterial narrowing who may benefit most 570 
from blood vessel dilation related to  dietary interventions [72, 73]. There is a possibility that 571 
a greater BP response would result in more pronounced cognitive functioning, which was not 572 
evident in the current study. In addition, it is recommended that blood and fecal samples are 573 
included in future human studies in order to allow a more comprehensive analysis of in vivo 574 
metabolites, specifically generated by the gut microbiota and thereby elucidate the mode of 575 
action of these plant bioactives. 576 
 577 
In conclusion, our research hypothesis was not accepted as there were no differences 578 
according to two dose-timing regimens of consumption of QGPJ. An acute BP-lowering 579 
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effect of anthocyanin-rich plum juice was similarly observed for both dose-timing regimens, 580 
while no cognitive effects were observed for either dose, nor were differences in anthocyanin 581 
metabolite excretion evident between younger and older adults. Anthocyanin metabolites 582 
were bioavailable in urine following consumption but no differences were observed in the 583 
absorption rate and metabolism of anthocyanins between young and older adults, assessed in 584 
urine. It is important that the mechanism of action is studied further to better understand how 585 
anthocyanins exert protective effects on BP and how this reduction effect can be sustained 586 
over time, as well as the effects on cognition in longer-term consumption studies. With more 587 
significant effects observed in older participants, future studies should focus on this age 588 
group where elevated BP is more prevalent by using a placebo-controlled design.  589 
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Table 1: Subjects’ characteristics   
Characteristics 
 
Younger adults 
(n=12) 
n (%) 
Older adults (n=12) 
n (%) 
p-values 
Gender 
Male  
 
Female 
 
 
4 (33.3) 
 
8 (66.7) 
 
3 (25.0) 
 
9 (75.0) 
 
Ns 
Age (Means ± SD) 
 
31 (8) 77 (6) <0.001 
BMI (Means ± SD) 
 
22.5 (2.4) 26.4 (3.3) 0.003 
Physical Activity 
Low 
 
Medium 
 
High 
 
 
5 (41.7) 
 
5 (41.7) 
 
2 (16.7) 
 
1 (8.3) 
 
10 (83.3) 
 
1 (8.3) 
 
0.97 
Smoking status 
Yes 
 
No 
 
Occasionally 
 
Rarely 
 
 
0 (0) 
 
11 (91.7) 
 
0 (0) 
 
1 (8.3) 
 
0 (0) 
 
12 (100) 
 
0 (0) 
 
0 (0) 
 
Ns 
Alcohol intake 
Yes 
 
No 
 
Occasionally 
 
Rarely 
 
3 (25.0) 
 
2 (17.7) 
 
4 (33.3) 
 
3 (25.0) 
 
5 (41.7) 
 
3 (25.0) 
 
2 (16.7) 
 
2 (16.7) 
 
0.67 
Data are means ± SD or n (%) (n=12) 
BMI – Body Mass Index 
P values were obtained from χ2 test for categorical variables. 
Ns- Not significant 
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Fig. 1a: Single dose hourly systolic blood pressure of participants over 24h after 
consumption of QGP juice 
 
 
Data are expressed as mean values ± SE (error bars) (n=12 per age group). BP, blood pressure; QGP, Queen Garnet 
plum. 
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Fig. 1b: Single dose hourly diastolic blood pressure of participants over 24h after 
consumption of QGP juice 
 
Data are expressed as mean values ± SE (error bars) (n=12 per age group). BP, blood pressure; QGP, Queen Garnet 
plum. 
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Fig. 2a: Single dose hourly mean arterial blood pressure of participants over 24h after 
consumption of QGP juice 
 
Data are expressed as mean values ± SE (error bars) (n=12 per age group). MAP, mean arterial pressure; QGP, 
Queen Garnet plum.  
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Fig. 2b: Single dose hourly heart rate of participants over 24h after consumption of 
QGP juice  
 
Data are expressed as mean values ± SE (error bars) (n=12 per age group). HR, heart rate; QGP, Queen Garnet 
plum.  
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Fig. 3a: Triple dose hourly systolic blood pressure of participants over 24h after 
consumption of QGP juice 
 
 
Data are expressed as mean values ± SE (error bars) (n=12 per age group). BP, blood pressure; QGP, Queen Garnet 
plum.  
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Fig: 3b: Triple dose hourly diastolic blood pressure of participants over 24h after consumption of QGP juice 
 Data are expressed as mean values ± SE (error bars) (n=12 per age group). BP, blood pressure; QGP, Queen Garnet 
plum.  
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Fig. 4a: Triple dose hourly mean arterial blood pressure of participants over 24h after 
consumption of QGP juice  
 
Data are expressed as mean values ± SE (error bars) (n=12 per age group). MAP, mean arterial pressure; QGP, 
Queen Garnet plum.  
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Fig. 4b: Triple dose hourly heart rate of participants over 24h after consumption of 
QGP juice  
 
Data are expressed as mean values ± SE (error bars) (n=12 per age group). HR, heart rate; QGP, Queen Garnet 
plum.  
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Fig.5a: Change in systolic blood pressure (0-6h) following consumption of QGP juice.  
 
 
Values are expressed as AUC for mean change in systolic blood pressure from baseline per hour up to 6h. 
Bars represent the sum of AUC for ∆SBP (0-6h) ± SE (n=12 per age group). AUC, Area Under the curve; 
QGPJ, Queen Garnet plum juice; SBP, Systolic blood pressure 
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Fig.5b: Change in diastolic blood pressure (0-6h) following consumption of QGP juice.   
 
 
 
Values are expressed as AUC for mean change in diastolic blood pressure from baseline per hour up to 
6h. Bars represent the sum of AUC for ∆DBP (0-6h) ± SE (n=12 per age group). AUC, Area Under the 
curve; QGPJ, Queen Garnet plum juice; DBP, Diastolic blood pressure 
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Fig. 6a: Change in MAP (0-6h) following consumption of QGP juice. 
 
Values are expressed as AUC for mean change in MAP from baseline per hour up to 6h. Bars represent 
the sum of AUC for ∆MAP (0-6h) ± SE (n=12 per age group). AUC, Area Under the curve; QGPJ, Queen 
Garnet plum juice; MAP, mean arterial pressure 
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Fig. 6b: Change in heart rate (0-6h) following consumption of QGP juice. 
 
Values are expressed as AUC for mean change in HR from baseline per hour up to 6h. Bars represent the 
sum of AUC for ∆HR (0-6h) ± SE (n=12 per age group). AUC, Area Under the curve; QGPJ, Queen 
Garnet plum juice; HR, heart rate. 
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Table 2: Effect of dose-timed plum juice consumption on cardiovascular parameters 
across age groups 
 
Parameter 
 
Mean ± SE p-values 
SBP 
Intercept 
 
Dose-time 
1 x 300ml 
3 x 100ml 
 
Group 
Younger 
Older 
 
Interaction (group*dose) 
Younger * 1x300ml 
Younger * 3x100ml 
 
Older * 1x300ml 
Older * 3x100ml 
 
DBP 
Intercept 
 
Dose-time 
1 x 300ml 
3 x 100ml 
 
Group 
Younger 
Older 
 
Interaction (group*dose) 
Younger * 1x300ml 
Younger * 3x100ml 
 
Older * 1x300ml 
Older * 3x100ml 
 
MAP 
Intercept 
 
Dose-time 
1 x 300ml 
3 x 100ml 
 
 
 
123.7 ± 0.05 
 
 
122.3 ± 0.60  
125.2 ± 0.67 
 
 
115.0 ± 0.66 
132.8 ± 0.61 
 
 
114.2 ± 0.84 
115.8 ± 1.00 
 
130.3 ± 0.87 
134.5 ± 0.87 
 
 
72.9 ± 0.36 
 
 
72.5 ± 0.49 
73.3 ±0.54 
 
 
72.2 ± 0.53 
73.6 ± 0.49 
 
 
72.0 ± 0.68 
72.4 ±0.81 
 
73.0 ± 0.69 
74.1 ± 0.70 
 
 
90.2 ± 0.37  
 
 
89.4 ± 0.49 
90.9 ±0.54 
 
 
 
<0.0001^ 
 
 
0.001^ 
 
 
 
<0.0001^ 
 
 
0.154 
 
 
 
 
 
 
 
<0.0001^ 
 
 
0.25 
 
 
0.11 
 
 
 
 
0.62 
 
 
 
 
 
<0.0001^ 
 
 
0.077 
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Parameter 
 
Mean ± SE p-values 
Group 
Younger 
Older 
 
Interaction (group*dose) 
Younger * 1x300ml 
Younger * 3x100ml 
 
Older * 1x300ml 
Older * 3x100ml 
 
HR 
Intercept 
 
Dose-time 
1 x 300ml 
3 x 100ml 
 
Group 
Younger 
Older 
 
Interaction (group*dose) 
Younger * 1x300ml 
Younger * 3x100ml 
 
Older * 1x300ml 
Older * 3x100ml 
 
 
86.4 ± 0.54 
94.0 ± 0.50  
 
 
85.7 ± 0.68 
87.0 ± 0.83 
 
93.1 ± 0.70 
94.9 ± 0.70 
 
 
72.6 ± 0.36 
 
 
72.5 ± 0.49 
72.7 ± 0.54 
 
 
72.9 ± 0.54 
72.4 ± 0.49 
 
 
72.8 ± 0.69 
73.0 ± 0.82 
 
72.2 ±0.70 
72.5 ± 0.70 
<0.0001^ 
 
 
 
0.75 
 
 
 
 
 
 
 
<0.0001^ 
 
0.69 
 
 
 
0.76 
 
 
 
0.91 
Data are means ± SE (n=12 per group) 
^ Significant at p<0.05 
Means and p-values were obtained from linear mixed model  
“Younger” means younger age-group and “older” means older age-group 
Dose-time represents either a single dose of 300ml or 3 portions of 100ml taken at 0h, 1h and 3h  
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Table 3: Change in cardiovascular parameters of participants following consumption of 
different doses of QGP juice 
 
Cardiovascular parameters 
AUC (0-6 h), mmHg 
 
3 x 100ml QGP (0,1,3h) 
 
1 x 300ml QGP 
 
Younger adults (18-45) 
 
Systolic BP 
 
Diastolic BP 
 
Mean Arterial Pressure 
 
Heart Rate 
 
 
 
 
-49.36 ± 131.26 
 
-123.45 ± 122.27* 
 
-96.80 ± 12.75* 
 
-113.50 ± 208.69† 
 
 
 
 
-44.45 ± 125.29 
 
-140.55 ± 175.93* 
 
-125.40 ± 136.31* 
 
-164.42 ± 253.64* 
 
Older adults (65+) 
 
Systolic 
 
Diastolic 
 
Mean Arterial Pressure 
 
Heart Rate 
 
 
 
 
-172.50 ± 321.86 † 
 
-156.00 ± 136.28 * 
 
-97.67 ± 278.55 
 
-84.08 ± 195.42 
 
 
-191.00 ± 313.93* 
 
-121.33 ± 190.81* 
 
-149.92 ± 217.91* 
 
-136.17 ± 171.35* 
 
Data are AUC for mean change in cardiovascular parameters ± SD (n=12 per group) 
AUC – area under the curve; BP- blood pressure; QGP – Queen Garnet plum 
* Z-test analysis showed statistically significant effect of the juice on the measured parameter. 
† Z-test analysis showed borderline significant effect of the juice on the measured parameter. 
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Table 4: Urinary excretion of anthocyanins and anthocyanin metabolites in different 
age groups following the consumption of QGP juice as a single oral dose of 300ml or as 
three 100ml servings 
 Dosing 
(anthocyanins) 
Absolute 
excretion 
(µg/24 h)1 
Relative 
excretion 
(%)2 
 
Relative 
excretion of 
main 
metabolites 
(%)3 
Younger age 
group 
1x300 ml 
(369 mg) 
 
811 ± 702 
 
0.22 80 
3x100 ml 
(123 mg/dose) 
 
759 ± 358 0.21 74 
Older age 
group 
1x300 ml 
(369 mg) 
 
871 ± 602 0.24 80 
3x100 ml 
(123 mg/dose) 
 
693 ± 458 0.19 75 
Data are means ± SD (n=12 per group); 1sum of cyanidin-3-glucoside, cyanidin-3-rutinoside, cyanidin-3-glucoside 
monoglucuronide, cyanidin monoglucuronide, peonidin-3-glucoside, peonidin monoglucuronide and pelargonidin 
monoglucuronide; 2excreted amount vs. ingested dose; 3excreted amount of peonidin-3-glucoside and peonidin 
monoglucuronide as the main metabolites vs. absolute excretion; compounds were analyzed by HPLC-PDA-MS and 
quantified by an external cyanidin-3-glucoside calibration curve [36] 
